Nicole Hendrickson
Family · Spring Grove, ILNPI 1881242725
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 27.5% of the total. 2025 is the largest year on record at $1,979, more than ten times the $29 reported in 2021. Among family clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Tris Pharma Inc$966
- Corium, LLC$437
- Axsome Therapeutics, Inc.$407
- Neurocrine Biosciences, Inc.$305
- Neos Therapeutics, LP$209
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,737100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,304 |
| Tris Pharma Inc | 41 | $966 |
| Corium, LLC | 30 | $437 |
| Axsome Therapeutics, Inc. | 25 | $407 |
| Neurocrine Biosciences, Inc. | 8 | $305 |
| Neos Therapeutics, LP | 12 | $209 |
| Alkermes, Inc. | 10 | $173 |
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $119 |
| Ironshore Pharmaceuticals Inc. | 6 | $115 |
| Lundbeck LLC | 4 | $76 |
| Bayer | 3 | $72 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $69 |
| Supernus Pharmaceuticals, Inc. | 4 | $65 |
| Pfizer | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Noven Therapeutics, LLC | 2 | $33 |
| Novo Nordisk | 1 | $28 |
| Bausch Health US, LLC | 1 | $21 |
| Phadia US Inc. | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Merck | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| GSK | 1 | $16 |
| Novartis | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Aurinia Pharma U.S., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$241
- Quillivant$241
- Quillichew ER$241
- VRAYLAR$239
- INGREZZA$121
- Azstarys$109
How this compares
$4,737 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 25 | $852 |
| Gabapentin | 13 | $270 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $258 |
Paid to pharmacies, not to this prescriber.
Other family in Spring Grove
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.